In 2006, AstraZeneca acquired Cambridge Antibody Technology, a biotechnology company specializing in the discovery and development of human therapeutic antibodies. This acquisition helped strengthen AstraZeneca's research and development capabilities.
Unlock the AstraZeneca Enigma: The Ultimate Quiz on the British Pharma Giant!